Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05390385 · ClinicalTrials.gov registry record · NA
Acceptability and Tolerability of Ketone Supplements and Effects of BHB Concentrations in Young Adults
A NA study, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- NA
- Development phase
- 14
- Enrollment target
NCT05390385 is a NA study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 14 participants.
The verdict
NCT05390385, a NA study, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
Study Summary
Assess the acceptability and tolerability of two different commercially available ketone supplements and determine their effects on capillary blood concentrations of the ketone beta-hydroxybutyrate and glucose in young adults.
Interventions
- OTHER Placebo drink
- DIETARY_SUPPLEMENT KE1 5g
- DIETARY_SUPPLEMENT KE1 10g
- DIETARY_SUPPLEMENT KE4 5g
- DIETARY_SUPPLEMENT KE 10g
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2022-09-23 |
| Est. Completion | 2023-08-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05390385
The ClinicalTrials.gov registry entry for NCT05390385 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Placebo drink is the first listed.
NCT05390385 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05390385 about?
NCT05390385 is a clinical study titled "Acceptability and Tolerability of Ketone Supplements and Effects of BHB Concentrations in Young Adults". Assess the acceptability and tolerability of two different commercially available ketone supplements and determine their effects on capillary blood concentrations of the ketone beta-hydroxybutyrate and glucose in young adults.
What is the current status of trial NCT05390385?
This trial is currently completed. It is a NA study. The enrollment target is 14 participants. The study started on 2022-09-23. Estimated completion is 2023-08-15.
What interventions are being tested in trial NCT05390385?
The interventions under investigation include: Placebo drink (OTHER), KE1 5g (DIETARY_SUPPLEMENT), KE1 10g (DIETARY_SUPPLEMENT), KE4 5g (DIETARY_SUPPLEMENT), KE 10g (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05390385?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.